KNBIF (Kane Biotech) Price-to-Operating-Cash-Flow: (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kane Biotech Price-to-Operating-Cash-Flow?

As of today (2026-09-05), Kane Biotech's share price is $0.01665. Kane Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.01. Hence, Kane Biotech's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Kane Biotech's Price-to-Operating-Cash-Flow or its related term are showing as below:

KNBIF's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 23.6
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Kane Biotech's Cash Flow from Operations per share for the three months ended in Jun. 2026 was $-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 7.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 7.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.00% per year.

During the past 13 years, Kane Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 44.10% per year. The lowest was -31.50% per year. And the median was 10.50% per year.

Kane Biotech Price-to-Operating-Cash-Flow Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Price-to-Operating-Cash-Flow Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kane Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

KNBIF vs VRTX, REGN, MRNA: Price-to-Operating-Cash-Flow Comparison

For the Biotechnology subindustry, Kane Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech Price-to-Operating-Cash-Flow vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Kane Biotech's Price-to-Operating-Cash-Flow falls into.


Kane Biotech Price-to-Operating-Cash-Flow Calculation

Kane Biotech's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.01665/-0.01
=

Kane Biotech's Share Price of today is $0.01665.
Kane Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.